We corroborated PFC GFAP+ enhanced activity using the DREADD approach (increases GFAP+/Fosb+ cells in no CRS animals), which rules out hM3D(Gq) receptor desensitization following chronic CNO treatment in our experiment(56). Here, GFAP is linked to congenital rubella syndrome.